Live Breaking News & Updates on Okava Pharmaceuticals
Stay updated with breaking news from Okava pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Vivani Medical announced proof-of-concept data for a subdermal exenatide implant designed for feline obesity and diabetes, which was published in BMC Veterinary Research. ....
Vivani Medical, Inc. (VANI) Tuesday announced positive proof-of-concept weight loss data with OKV-119, a miniature, subdermal, exenatide drug implant designed to treat feline obesity and diabetes. ....
The following slides and any accompanying oral presentation contain forward-looking statements within the meaning of Section 27A of the Securities Act. ....